192 related articles for article (PubMed ID: 18525317)
1. Sex dimorphism in antitumor response of chemotherapeutic drug cisplatin in a murine host-bearing a T-cell lymphoma.
Gupta V; Singh SM
Anticancer Drugs; 2008 Jul; 19(6):583-92. PubMed ID: 18525317
[TBL] [Abstract][Full Text] [Related]
2. Gender dimorphism in the myeloid differentiation of bone marrow precursor cells in a murine host bearing a T cell lymphoma.
Gupta V; Singh SM
J Reprod Immunol; 2007 Jun; 74(1-2):90-102. PubMed ID: 17275917
[TBL] [Abstract][Full Text] [Related]
3. Effect of high cell density on the growth properties of tumor cells: a role in tumor cytotoxicity of chemotherapeutic drugs.
Singh V; Singh SM
Anticancer Drugs; 2007 Nov; 18(10):1123-32. PubMed ID: 17893512
[TBL] [Abstract][Full Text] [Related]
4. Prolactin promotes growth of a spontaneous T cell lymphoma: role of tumor and host derived cytokines.
Singh MP; Sharma H; Singh SM
Cancer Invest; 2006 Oct; 24(6):601-10. PubMed ID: 16982465
[TBL] [Abstract][Full Text] [Related]
5. Gender dimorphism of tumor growth: role of gonadal hormones in differential regulation of apoptosis of a murine T cell lymphoma.
Gupta V; Singh SM
J Biomed Sci; 2008 Mar; 15(2):147-62. PubMed ID: 17965948
[TBL] [Abstract][Full Text] [Related]
6. Gender dimorphism of macrophage response to GMCSF and IL-4 for differentiation into dendritic cells.
Gupta V; Singh SM
Am J Reprod Immunol; 2008 Jul; 60(1):43-54. PubMed ID: 18593437
[TBL] [Abstract][Full Text] [Related]
7. A tumour stage-dependent evolution of drug resistant T cell lymphoma: role of soluble mediators of tumour and host origin.
Singh V; Singh SM
Leuk Res; 2009 May; 33(5):700-9. PubMed ID: 18930317
[TBL] [Abstract][Full Text] [Related]
8. Immunopotentiation in mice bearing a spontaneous transplantable T-cell lymphoma: role of thymic extract.
Shanker A; Singh SM
Neoplasma; 2003; 50(4):272-9. PubMed ID: 12937840
[TBL] [Abstract][Full Text] [Related]
9. Gender-specific antitumor action of aspirin in a murine model of a T-cell lymphoma bearing host.
Kumar A; Vishvakarma NK; Bharti AC; Singh SM
Blood Cells Mol Dis; 2012 Feb; 48(2):137-44. PubMed ID: 22104368
[TBL] [Abstract][Full Text] [Related]
10. Gender dimorphism in the progressive in vivo growth of a T cell lymphoma: involvement of cytokines and gonadal hormones.
Singh MP; Rai AK; Singh SM
J Reprod Immunol; 2005 Feb; 65(1):17-32. PubMed ID: 15694964
[TBL] [Abstract][Full Text] [Related]
11. Gender variation in interleukin-13 production: a possible mechanism of differential in vivo growth of a T-cell lymphoma.
Deepak P; Kumar S; Acharya A
Scand J Immunol; 2008 Jun; 67(6):581-8. PubMed ID: 18397198
[TBL] [Abstract][Full Text] [Related]
12. Anti-neoplastic action of aspirin against a T-cell lymphoma involves an alteration in the tumour microenvironment and regulation of tumour cell survival.
Kumar A; Vishvakarma NK; Tyagi A; Bharti AC; Singh SM
Biosci Rep; 2012 Feb; 32(1):91-104. PubMed ID: 21692746
[TBL] [Abstract][Full Text] [Related]
13. IL-13 Ralpha2-mediated interleukin-13 neutralization represses in vivo progressive growth of a T-cell lymphoma.
Deepak P; Sanjay K; Acharya A
J Exp Clin Cancer Res; 2007 Sep; 26(3):347-52. PubMed ID: 17987794
[TBL] [Abstract][Full Text] [Related]
14. Augmentation of myelopoiesis in a murine host bearing a T cell lymphoma following in vivo administration of proton pump inhibitor pantoprazole.
Vishvakarma NK; Singh SM
Biochimie; 2011 Oct; 93(10):1786-96. PubMed ID: 21722701
[TBL] [Abstract][Full Text] [Related]
15. Use of subtherapeutical dose of cisplatin and vitamin C against murine Dalton's lymphoma.
Prasad SB; Giri A; Arjun J
Pol J Pharmacol Pharm; 1992; 44(4):383-91. PubMed ID: 1287602
[TBL] [Abstract][Full Text] [Related]
16. Chemo-immunotherapeutical studies on Dalton's lymphoma in mice using cisplatin and ascorbic acid: synergistic antitumor effect in vivo and in vitro.
Sarna S; Bhola RK
Arch Immunol Ther Exp (Warsz); 1993; 41(5-6):327-33. PubMed ID: 8010874
[TBL] [Abstract][Full Text] [Related]
17. PNAS-4, a novel pro-apoptotic gene, can potentiate antineoplastic effects of cisplatin.
Yuan Z; Yan F; Wang YS; Liu HY; Gou LT; Zhao XY; Lai ST; Deng HX; Li J; Ding ZY; Xiong SQ; Kan B; Mao YQ; Chen LJ; Wei YQ; Zhao X
Cancer Chemother Pharmacol; 2009 Dec; 65(1):13-25. PubMed ID: 19387645
[TBL] [Abstract][Full Text] [Related]
18. Transforming growth factor-beta 1 overexpression produces drug resistance in vivo: reversal by decorin.
Teicher BA; Ikebe M; Ara G; Keyes SR; Herbst RS
In Vivo; 1997; 11(6):463-72. PubMed ID: 9509296
[TBL] [Abstract][Full Text] [Related]
19. Antitumor and chemosensitizing action of dichloroacetate implicates modulation of tumor microenvironment: a role of reorganized glucose metabolism, cell survival regulation and macrophage differentiation.
Kumar A; Kant S; Singh SM
Toxicol Appl Pharmacol; 2013 Nov; 273(1):196-208. PubMed ID: 24051182
[TBL] [Abstract][Full Text] [Related]
20. Novel molecular mechanisms of antitumor action of dichloroacetate against T cell lymphoma: Implication of altered glucose metabolism, pH homeostasis and cell survival regulation.
Kumar A; Kant S; Singh SM
Chem Biol Interact; 2012 Jul; 199(1):29-37. PubMed ID: 22705712
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
